Goodwin Advises Zus Health on Its $33 Million Series B Financing
The Healthcare and Technology teams advised Zus Health ("Zus") on its $33 million Series B financing to accelerate the next generation of connected healthcare. The financing was led by Drive Capital, with participation from Sanofi Ventures, HealthX Ventures, and Alumni Ventures, as well as existing investors Andreessen Horowitz (a16z), F-Prime, Maverick Ventures, and JAZZ Venture Partners. The financing brings Zus' total capital raised to more than $100 million and will support the company's continued investment in its intelligent patient record platform, national healthcare data network, and AI-powered clinical workflows.
Zus Health is an AI-native healthcare data platform that brings fragmented patient information together to make it complete, current, and actionable. Through its nationwide data network, platform, and intelligent workflows, Zus helps providers, value-based care organizations, payers, life sciences, and digital health companies drive business results, strengthen provider trust, and improve operational efficiency. Founded in 2021 by Jonathan Bush, co-founder and former CEO of athenahealth, Zus is building the foundation for a more connected, precise, and effective healthcare system.
The Goodwin team was led by Dave Cappillo, Katie Hand, Meggie Hickey, Paul Rosie, Katie Adams, and Adam DiTullio.
For more information on the deal, please read the press release.